[1]
|
IAP/APA (2013) Evidence-Based Guidelines for the Management of Acute Pancreatitis. Pancreatology: Official Journal of the International Association of Pancreatology (IAP), 13, e1-e15.
|
[2]
|
Johnstone, M., Marriott, P., Royle, T.J., Richardson, C.E., Torrance, A., Hepburn, E., et al. (2014) The Impact of Timing of Cholecystectomy Following Gallstone Pancreatitis. The Surgeon: Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 12, 134-140.
|
[3]
|
Tenner, S., Baillie, J., DeWitt, J. and Vege, S.S. (2013) American College of Gastroenterology Guideline: Management of Acute Pancreatitis. The American Journal of Gastroenterology, 108, 1400-1416.
|
[4]
|
Kim, D.B., Cho, Y.K., Song, H.J. and Song, B.C. (2013) A Case of Acute Pancreatitis and Acute Hepatitis Caused by Ingestion of Ceramiumkondoi. The Korean Journal of Gastroenterology, 62, 306-309.
|
[5]
|
Sekimoto, M., Takada, T., Kawarada, Y., Hirata, K., Mayumi, T., Yoshida, M., Hirota, M., Kimura, Y., Takeda, K., Isaji, S., et al. (2006) JPN Guidelines for the Management of Acute Pancreatitis: Epidemiology, Etiology, Natural History, and Outcome Predictors in Acute Pancreatitis. Journal of Hepato-Biliary-Pancreatic Surgery, 13, 10-24. http://dx.doi.org/10.1007/s00534-005-1047-3
|
[6]
|
Vinklerova, I., Prochazka, M., Prochazka, V. and Urbanek, K. (2010) Incidence, Severity, and Etiology of Drug-Induced Acute Pancreatitis. Digestive Diseases and Sciences, 55, 2977-2981. http://dx.doi.org/10.1007/s10620-010-1277-3
|
[7]
|
Lankisch, P.G., Droge, M. and Gottesleben, F. (1995) Drug Induced Acute Pancreatitis: Incidence and Severity. Gut, 37, 565-567. http://dx.doi.org/10.1136/gut.37.4.565
|
[8]
|
Garg, R., Chen, W. and Pendergrass, M. (2010) Acute Pancreatitis in Type 2 Diabetes Treated with Exenatide or Sitagliptin: A Retrospective Observational Pharmacy Claims Analysis. Diabetes Care, 33, 2349-2354. http://dx.doi.org/10.2337/dc10-0482
|
[9]
|
Neoptolemos, J.P., Raraty, M., Finch, M. and Sutton, R. (1998) Acute Pancreatitis: The Substantial Human and Financial Costs. Gut, 42, 886-891. http://dx.doi.org/10.1136/gut.42.6.886
|
[10]
|
Soran, A., Chelluri, L., Lee, K.K. and Tisherman, S.A. (2000) Outcome and Quality of Life of Patients with Acute Pancreatitis Requiring Intensive Care. The Journal of Surgical Research, 91, 89-94. http://dx.doi.org/10.1006/jsre.2000.5925
|
[11]
|
Badalov, N., Baradarian, R., Iswara, K., Li, J., Steinberg, W. and Tenner, S. (2007) Drug-Induced Acute Pancreatitis: An Evidence-Based Review. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association, 5, 648-661.
|
[12]
|
Engel, T., Justo, D., Amitai, M., Volchek, Y. and Mayan, H. (2013) Nilotinib-Associated Acute Pancreatitis. The Annals of Pharmacotherapy, 47, e3. http://dx.doi.org/10.1345/aph.1R334
|
[13]
|
Underwood, T.W. and Frye, C.B. (1993) Drug-Induced Pancreatitis. Clinical Pharmacy, 12, 440-448.
|